HomeDiscoveryOncology seminarsOncology seminars 2017

Oncology seminars 2017


November 10, 2017 (1:30 PM)
Anti-angiogenic therapy triggers metabolic rewiring in tumors 
Stefano Indraccolo
Istituto Oncologico Veneto (IOV) – IRCCS
Padova, Italy

October 24, 2017 (1:30 PM)
SERCA in T cell Acute Lymphoblastic Leukemia 
Giovanni Roti
Dipartimento di Medicina e Chirurgia, Università di Parma
Parma, Italy

October 23, 2017 (1:30 PM)
Patient-Derived Xenograft technology in support to translational and clinical oncological research
Stefano Cairo
Research and Development Xentech
Évry, France

October 20, 2017 (1:30 PM)
Epigenetic role of DNA transposable elements in shaping CD4+ T cell identity and plasticity in health and disease 
Beatrice Bodega, PhD
Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi”, Policlinico
Milano, Italy

September 28, 2017 (4:00 PM)
Chordoma: rare cancer, uncommon opportunities
Josh Sommer
Chordoma Foundation, San Raffaele
North Carolina

September 15, 2017 (11:30 AM)
CAR-T cell therapy: challenges and opportunities 
Attilio Bondanza, MD PhD
Innovative Immunotherapy Unit & Hematology and Bone Marrow Transplantation Unit, San Raffaele
Milano, Italy

June 23, 2017 (1:30 PM)
Integration of distinct endocytic pathways regulates the EGFR signaling output 
Sara Sigismund, PhD
IFOM, The FIRC Institute for Molecular Oncology Foundation
Milano, Italy

Jun 9, 2017 (1:30 PM)
One, no one, and one hundred thousand: new clues to the riddle of the mutant p53 oncogene 
Gianni Del Sal
Full Professor in Applied Biology, University of Trieste
Head of the Molecular Oncology Unit at the Laboratorio Nazionale CIB
Area Science Park, Trieste

May 19, 2017 (10:30 AM)
Antibody-based immunotherapy of solid tumors 
Soldano Ferrone
Harvard Medical School and Massachusetts General Hospital,
Boston, USA

May 12, 2017 (1:30 PM)
Patient derived tumor xenografts as a tool to improve ovarian patient prognosis 
Giovanna Damia
Head, DNA Repair Unit,
IRCCS - Istituto di Ricerche Farmacologiche Mario Negri

January 20, 2017 (1:30 PM)
Glioblastoma standard of care and future directions 
Gaetano Finocchiaro
Dipartimento di Neuro-Oncologia Molecolare,
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano